-
Lonza expands its bioconjugation facility in Visp, Switzerland
expresspharma
July 25, 2019
Lonza’s expansion will meet development, manufacturing needs of pharma and biotech companies developing a new generation of therapies
-
FDA Expands Approval of Cystic Fibrosis Treatment
americanpharmaceuticalreview
June 26, 2019
The U.S. Food and Drug Administration (FDA) expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.
-
FDA expands label of Vertex’s CF drug Symdeko to include younger children
pharmaceutical-technology
June 26, 2019
Vertex Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has expanded its approval of Symdeko (tezacaftor/ivacaftor and ivacaftor) to include cystic fibrosis (CF) patients aged six to ...
-
Kite Pharma Expands Mfg. Facility in MD
contractpharma
April 28, 2019
Kite Pharma, a Gilead company, plans to expand manufacturing capacity with a new biologics facility in Urbana, MD. Kite specializes in cancer treatments and is expanding its ability to provide both clinical and commercial treatments.
-
Sharp Expands US Operations
contractpharma
April 26, 2019
Sharp has invested $21 million in expanding capacity and capabilities at its Allentown and Conshohocken Pennsylvania facilities.
-
Dr. Reddy's Expands Commercial Operations in Europe
americanpharmaceuticalreview
February 10, 2017
Dr. Reddy's Laboratories Ltd. has announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France.